The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Yeah, a fair observation.
Also, I bought some more as the risk profile changed so guaranteed to try to spike me :)
But as I say, the risk profile has changed significantly today, is 20% uplift enough to represent that or should it be more?
Before we start stating takeover prices and generally criticising what is clearly a good RNS.
It is what wr needed, headline effectiveness and statistical significance.
Wish I'd bought more down here.
Have a good day all.
I think thier actions just before P3 results were all great. It was absolutely the right things to do.
They just got the trial sizes wrong, three times. Thats all they got wrong, but it's the most important thing (after creating a formula that works).
As you say in the past now. Hope for useful news from the data early next week.
Yeah, what worries me is that if its price sensitive, they really should have notified us. Unless they can justify it by saying the deep dive isn't complete until the day before yhe presentation.
We'll see I guess.
But we are where we are...
https://pharmaceutical-journal.com/article/feature/taking-the-p-why-the-founder-of-values-would-be-turning-in-his-grave
Tommy you may enjoy this article, any other LTH also.
That looks a lot like financial advice. Published financial advice. Not even any disclamers about the value of shares going down as well as up.
Strange thing to do.
So long term, are you up or down on this stock Andy? Perhaps thats something you should disclose when giving overt financial advice.